Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Summary

GlobalData, the industry analysis specialist, has released its new report, “Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Vitiligo Therapeutics market. The report identifies the key trends shaping and driving the global Vitiligo Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Vitiligo Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Vitiligo Therapeutics market. Its scope includes:

• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Vitiligo Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
• Analysis of the current and future competition in the seven key countries Vitiligo Therapeutics market.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Vitiligo Therapeutics market.
• Analysis of key recent licensing and partnership agreements in Vitiligo Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the global Vitiligo Therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Vitiligo Therapeutics market in future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
• What’s the next big thing in the global Vitiligo Therapeutics market landscape? – Identify, understand and capitalize.

Contents

1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 VITILIGO THERAPEUTICS - INTRODUCTION

2.1 Disease Overview
2.2 Epidemiology
2.3 Etiology and Pathophysiology
  2.3.1 Etiology of Vitiligo
  2.3.2 Pathophysiology of Vitiligo
2.4 Signs and Symptoms
2.5 Diagnosis
2.6 Treatment and Management Options
  2.6.1 Medical Therapies
  2.6.2 Surgical Therapies
  2.6.3 Additional Therapies
2.7 GlobalData Pipeline Report Guidance

3 VITILIGO THERAPEUTICS - MARKET CHARACTERIZATION

3.1 Vitiligo Therapeutics Market Size (2006-2011) - Global
3.2 Vitiligo Therapeutics Market Forecast (2011-2019) - Global
3.3 Vitiligo Therapeutics Market Size (2006-2011) - The US
3.4 Vitiligo Therapeutics Market Forecast (2011-2019) - The US
3.5 Vitiligo Therapeutics Market Size (2006-2011) - France
3.6 Vitiligo Therapeutics Market Forecast (2011-2019) - France
3.7 Vitiligo Therapeutics Market Size (2006-2011) - Germany
3.8 Vitiligo Therapeutics Market Forecast (2011-2019) - Germany
3.9 Vitiligo Therapeutics Market Size (2006-2011) - Italy
3.10 Vitiligo Therapeutics Market Forecast (2011-2019) - Italy
3.11 Vitiligo Therapeutics Market Size (2006-2011) - Spain
3.12 Vitiligo Therapeutics Market Forecast (2011-2019) - Spain
3.13 Vitiligo Therapeutics Market Size (2006-2011) - The UK
3.14 Vitiligo Therapeutics Market Forecast (2011-2019) - The UK
3.15 Vitiligo Therapeutics Market Size (2006-2011) - Japan
3.16 Vitiligo Therapeutics Market Forecast (2011-2019) - Japan
3.17 Drivers and Barriers for the Vitiligo Therapeutics Market
  3.17.1 Drivers for the Vitiligo Therapeutics Market
  3.17.2 Barriers for the Vitiligo Therapeutics Market
3.18 Opportunity and Unmet Need
3.19 Key Takeaway

4 VITILIGO THERAPEUTICS - COMPETITIVE ASSESSMENT

4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profile for the Major Marketed Products in the Vitiligo Therapeutics Market
  4.3.1 Topical Corticosteroids
  4.3.2 Topical Immunomodulators
  4.3.3 Methoxsalen
4.4 Key Takeaway

5 VITILIGO THERAPEUTICS - PIPELINE ASSESSMENT

5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Vitiligo Therapeutics - Pipeline Analysis by Clinical Phase of Development
  5.3.1 Vitiligo Therapeutics - Phase III Clinical Pipeline
  5.3.2 Vitiligo Therapeutics - Phase II Clinical Pipeline
  5.3.3 Vitiligo Therapeutics - Preclinical Phase Pipeline
5.4 Vitiligo Therapeutics - Pipeline by Mechanism of Action
5.5 Technology Trends Analytical Framework
5.6 Vitiligo Therapeutics - Most Promising Drugs in Clinical Development
5.7 Most Promising Drug Profiles
  5.7.1 Scenesse (afamelanotide)
5.8 Key Takeaway

6 VITILIGO THERAPEUTICS - CLINICAL TRIALS MAPPING

6.1 Clinical Trials by Region/Country (The US, EU5 and Japan)
6.2 Clinical Trials by Phase of Clinical Development
6.3 Clinical Trials by Trial Status
6.4 Prominent Sponsors
6.5 Clinical Trials by Sponsors
6.6 Top Companies Participating in Vitiligo Therapeutics Clinical Trials

7 VITILIGO THERAPEUTICS - STRATEGIC ASSESSMENT

7.1 Key Events Impacting the Future Market
7.2 Future Market Competition Scenario

8 VITILIGO THERAPEUTICS - FUTURE PLAYERS

8.1 Introduction
8.2 Company Profiles
  8.2.1 Clinuvel Pharmaceuticals
  8.2.2 Switch Biotech
  8.2.3 Dermira
8.3 Key Takeaway

9 VITILIGO THERAPEUTICS - LICENSING & PARTNERSHIP DEALS

10 VITILIGO THERAPEUTICS - APPENDIX

10.1 Definitions
10.2 Acronyms
10.3 Research Methodology
  10.3.1 Coverage
  10.3.2 Secondary Research
  10.3.3 Forecasting
  10.3.4 Primary Research
  10.3.5 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

LIST OF TABLES

Table 1: Characteristics of Various Types of Vitiligo
Table 2: Vitiligo Prevalence in Seven Major Markets
Table 3: Vitiligo Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 4: Vitiligo Therapeutics Market, Global, Forecast ($m), 2011-2019
Table 5: Vitiligo Therapeutics Market, The US, Revenue ($m), 2006-2011
Table 6: Vitiligo Therapeutics Market, The US, Forecast ($m), 2011-2019
Table 7: Vitiligo Therapeutics Market, France, Revenue ($m), 2006-2011
Table 8: Vitiligo Therapeutics Market, France, Forecast ($m), 2011-2019
Table 9: Vitiligo Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 10: Vitiligo Therapeutics Market, Germany, Forecast ($m), 2011-2019
Table 11: Vitiligo Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 12: Vitiligo Therapeutics Market, Italy, Forecast ($m), 2011-2019
Table 13: Vitiligo Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 14: Vitiligo Therapeutics Market, Spain, Forecast ($m), 2011-2019
Table 15: Vitiligo Therapeutics Market, The UK, Revenue ($m), 2006-2011
Table 16: Vitiligo Therapeutics Market, The UK, Forecast ($m), 2011-2019
Table 17: Vitiligo Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 18: Vitiligo Therapeutics Market, Japan, Forecast ($m), 2011-2019
Table 19: Vitiligo Therapeutics Market, Phase III Pipeline, 2011
Table 20: Vitiligo Therapeutics Market, Phase II Pipeline, 2011
Table 21: Vitiligo Therapeutics Market, Pre-clinical and Discovery Phase Pipeline, 2011
Table 22: Vitiligo Therapeutics Market, Global, Most Promising Drugs in Clinical Development, 2011
Table 23: Vitiligo Therapeutics, Global, Clinical Trials, 2011
Table 24: Vitiligo Therapeutics, Global, Clinical Trials by Phase, 2011
Table 25: Vitiligo Therapeutics, Global, Clinical Trials by Status of Development, 2011
Table 26: Vitiligo Therapeutics, Global, Prominent Sponsors, 2011
Table 27: Vitiligo Therapeutics, Global, Overall Sponsors, 2011
Table 28: Vitiligo Therapeutics, Global, Top Companies by Phase, 2011
Table 29: Clinuvel Pharmaceuticals - Vitiligo, Pipeline, 2011
Table 30: Switch Biotech - Vitiligo, Pipeline, 2011
Table 31: Dermira - Vitiligo, Pipeline, 2011
Table 32: Vitiligo Therapeutics, Global, Deals - 2011

LIST OF FIGURES

Figure 1: Graphic Presentation of Vitiligo
Figure 2: Vitiligo Therapeutics Market, Global, Revenue ($m), 2006-2011
Figure 3: Vitiligo Therapeutics Market, Global, Forecast ($m), 2011-2019
Figure 4: Vitiligo Therapeutics Market, The US, Revenue ($m), 2006-2011
Figure 5: Vitiligo Therapeutics Market, The US, Forecast ($m), 2011-2019
Figure 6: Vitiligo Therapeutics Market, France, Revenue ($m), 2006-2011
Figure 7: Vitiligo Therapeutics Market, France, Forecast ($m), 2011-2019
Figure 8: Vitiligo Therapeutics Market, Germany, Revenue ($m), 2006-2011
Figure 9: Vitiligo Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 10: Vitiligo Therapeutics Market, Italy, Revenue ($m), 2006-2011
Figure 11: Vitiligo Therapeutics Market, Italy, Forecast ($m), 2011-2019
Figure 12: Vitiligo Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 13: Vitiligo Therapeutics Market, Spain, Forecast ($m), 2011-2019
Figure 14: Vitiligo Therapeutics Market, The UK, Revenue ($m), 2006-2011
Figure 15: Vitiligo Therapeutics Market, The UK, Forecast ($m), 2011-2019
Figure 16: Vitiligo Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 17: Vitiligo Therapeutics Market, Japan, Forecast ($m), 2011-2019
Figure 18: Opportunity and Unmet Need in the Vitiligo Therapeutics Market
Figure 19: Strategic Competitor Assessment of the Marketed Products in Vitiligo Therapeutics, 2011
Figure 20: Vitiligo Therapeutics Pipeline by Phase of Clinical Development, 2011
Figure 21: Vitiligo Therapeutics Market, Global, Pipeline by Mechanism of Action (%), 2011
Figure 22: Technology Trends Analytics Framework, 2011
Figure 23: Technology Trends Analytics Framework - Description, 2011
Figure 24: Vitiligo Therapeutics, Global, Clinical Trials by Country, 2011
Figure 25: Vitiligo Therapeutics, Global, Clinical Trials by Phase (%), 2011
Figure 26: Vitiligo Therapeutics, Global, Clinical Trials by Status of Development (%), 2011
Figure 27: Vitiligo Therapeutics, Global, Prominent Sponsors (%), 2011
Figure 28: Vitiligo Therapeutics, Global, Overall Sponsors (%), 2011
Figure 29: Vitiligo Therapeutics Market, Drivers and Restraints, 2011
Figure 30: Implications for Future Market Competition in the Vitiligo Therapeutics Market, 2011
Figure 31: Vitiligo Therapeutics Market, Global, Future Players, 2011
Figure 32: GlobalData Market Forecasting Model

COMPANIES MENTIONED

Clinuvel Pharmaceuticals
Switch Biotech
Dermira Skip to top